Page last updated: 2024-10-22

amifostine anhydrous and Carcinoma 256, Walker

amifostine anhydrous has been researched along with Carcinoma 256, Walker in 3 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Carcinoma 256, Walker: A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"The WR-1065 tumor portal dosing AUC15-60 was 40% of systemic dosing, and tumor concentrations following portal dosing were one-fifth of that following systemic dosing."1.32Disposition of WR-1065 in the liver of tumor-bearing rats following regional vs systemic administration of amifostine. ( DeRemer, SJ; Dou, C; Ensminger, WD; Levi, M; Smith, DE, 2004)
"The rat Walker carcinosarcoma 256 is an animal model for humoral hypercalcaemia of malignancy (HHM)."1.28Relative role of bone and kidney in the hypercalcaemia associated with the rat Walker carcinosarcoma 256. ( Esbrit, P; Hurtado, J; Rapado, A, 1991)
"In vitro bone resorption assays utilizing fetal rat long bones in organ culture showed complementary results."1.27In vivo and in vitro effects of WR-2721 in experimental hypercalcemia in the rat. ( Fallon, M; Goldfarb, S; Walker, ST; Weiss, J, 1986)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Levi, M1
DeRemer, SJ1
Dou, C1
Ensminger, WD1
Smith, DE1
Hurtado, J1
Esbrit, P1
Rapado, A1
Weiss, J1
Walker, ST1
Fallon, M1
Goldfarb, S1

Other Studies

3 other studies available for amifostine anhydrous and Carcinoma 256, Walker

ArticleYear
Disposition of WR-1065 in the liver of tumor-bearing rats following regional vs systemic administration of amifostine.
    Biopharmaceutics & drug disposition, 2004, Volume: 25, Issue:1

    Topics: Amifostine; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Disease Models, Animal; Drug Deli

2004
Relative role of bone and kidney in the hypercalcaemia associated with the rat Walker carcinosarcoma 256.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:1

    Topics: Amifostine; Animals; Bone and Bones; Calcium; Carcinoma 256, Walker; Diphosphonates; Female; Hyperca

1991
In vivo and in vitro effects of WR-2721 in experimental hypercalcemia in the rat.
    The Journal of pharmacology and experimental therapeutics, 1986, Volume: 238, Issue:3

    Topics: Amifostine; Animals; Bone Resorption; Calcitriol; Carcinoma 256, Walker; Female; Glutathione; Hyperc

1986